openPR Logo
Press release

Global Methicillin-Resistant Staphylococcus Aureus Drugs Industry 2018 Market Research Report, Popular Trends & Technological Advancements, Forecast & Opportunities

04-09-2019 02:44 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Infinium Global Research

/ PR Agency: Methicillin-Resistant Staphylococcus Aureus Drugs
Methicillin-Resistant Staphylococcus Aureus Drugs

Methicillin-Resistant Staphylococcus Aureus Drugs

We have produced a new premium report Methicillin-Resistant Staphylococcus Aureus Drugs Market. The report covers the analysis of global as well as regional markets of Methicillin-Resistant Staphylococcus Aureus Drugs. The objective of the study is to identify market sizes of different segments & countries in recent years and to forecast the values for the next six years. The report also deep dives into the sub-segments of Methicillin-Resistant Staphylococcus Aureus Drugs Market by drug class (cephalosporin, lipopeptides, lipoglycopeptide, folate antagonist, tetracycline, oxazolidinone), MOA (bactericidal drugs, bacteriostatic), drug origin (synthetic drugs, semisynthetic) through main geographies in the Global Market such as North America, Europe, Asia-Pacific and RoW.

The report covers market changing aspects including drivers, restraints, opportunities, and trends expected to encourage the expansion of the Methicillin-Resistant Staphylococcus Aureus Drugs Market during the said period. The report also provides market attractiveness analysis, by geography, and market share analysis, by key players respectively. Some of the prominent participants in the Global Methicillin-Resistant Staphylococcus Aureus Drugs Market are Theravance Biopharma, Basilea Pharmaceutica, Pfizer, Debiopharm Group, Merck, Allergan, Melinta Therapeutics, AmpliPhi Biosciences Corporation, KYORIN Pharmaceutical Co. Ltd. and Baxter International.

For More Details Get Free Sample Pages of this Research Report@ https://www.infiniumglobalresearch.com/reports/sample-request/1187

The report also identifies the drivers and restraints that affect the Methicillin-Resistant Staphylococcus Aureus Drugs market over the period of 2018 to 2024.

Increased funding for antibiotic research

Increased funding for antibiotic research and patient assistance programs are the recent market trends in the global Methicillin-Resistant Staphylococcus Aureus Drugs market. Moreover, this trend is further anticipated to drive the global Methicillin-Resistant Staphylococcus Aureus Drugs market over the forecast period. Furthermore, the growing patient pool of low income and uninsured patients, as well as high unmet needs in the market, are the key factors responsible for the increased funding for antibiotic research and patient assistance programs.

Growing incidences of infections and rising aging population

Growing incidences of infections and rising aging population are the key factor responsible for the growth of global Methicillin-Resistant Staphylococcus Aureus Drugs market. Moreover, high contagious nature of this infection and difficulties in treatment due to its resistance to commonly used antibiotics such as methicillin is the key factor responsible for the growth of growing incidences of infections. Furthermore, the aging population are easily prone to infections and diseases across hospitals and healthcare facilities owing to their weak immune systems.

North America region is the largest consumer among the geographies followed by Europe while APAC to grow at the highest CAGR

The global Methicillin-Resistant Staphylococcus Aureus Drugs market has been dominated by the North America region over the historic period 2015-16 followed by Europe. Presence of developed healthcare infrastructure coupled with co-pay assistance programs for patients and rising initiatives for the approval of new antibiotics owing to favorable regulations are the prime factor responsible for the growth of Methicillin-Resistant Staphylococcus Aureus Drugs market in this region. Furthermore, the Asia-Pacific region is expected to grow at the highest CAGR over the period of 2018 to 2024. Moreover, raising awareness among the population about the antibiotic-resistant bacterial infections and growing incidences of hospital-acquired disease in the developing economies are anticipated to boost the market for Methicillin-Resistant Staphylococcus Aureus Drugs.

Purchase Global Methicillin-Resistant Staphylococcus Aureus Drugs market by drug class (cephalosporin, lipopeptides, lipoglycopeptide, folate antagonist, tetracycline and oxazolidinone), by MOA (bactericidal drugs and bacteriostatic), by drug origin (synthetic drugs and semisynthetic) and by region (North America, Europe, Asia Pacific, Latin America and RoW) report on https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-methicillin-resistant-staphylococcus-aureus-drugs-market

Major Key Players Mentioned in this Premium Report@

The companies covered in the report include Theravance Biopharma, Basilea Pharmaceutica, Pfizer, Debiopharm Group, Merck, Allergan, Melinta Therapeutics, AmpliPhi Biosciences Corporation, KYORIN Pharmaceutical Co. Ltd. and Baxter International.

Reasons to buy this report

Comprehensive analysis of global as well as regional markets of Methicillin-Resistant Staphylococcus Aureus Drugs

Complete coverage of all the product type and applications segments to analyze the trends, developments, and forecast of market size up to 2024.

Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.

Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Infinium Global Research and Consulting Solutions is started with a single motto of being a business partner of the first choice. We at Infinium work on the strengths of our clients to ensure we help them consolidate their market position. We firmly believe in the fact that ‘if you are able to develop newer opportunities then you find there is no dearth of opportunities for you. With our strategic research approaches and deep dive in the market segments, we try to find out new opportunities that our clients can encash with their existing resources. Our experts with over 100 years of cumulative experience in research offer the best in the industry services to our clients to ensure that they achieve their business goals.

Infinium Global Research
Office No. 04, 06, Ganadhish Empire,
Rahatani Corner, Pune, MH 411027
Email: info@infiniumglobalresearch.com
Website: www.infiniumglobalresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Methicillin-Resistant Staphylococcus Aureus Drugs Industry 2018 Market Research Report, Popular Trends & Technological Advancements, Forecast & Opportunities here

News-ID: 1695715 • Views:

More Releases from Infinium Global Research

Global Aircraft Tyre Market Size Worth USD 2478.09 Million By 2030 | CAGR 5.47%: Infinium Global Research
Global Aircraft Tyre Market Size Worth USD 2478.09 Million By 2030 | CAGR 5.47%: …
Infinium Global Research, a prominent market research firm, has released an in-depth report providing a comprehensive analysis of the Global Aircraft Tyre Market. The report dives into segments and sub-segments, highlighting both global trends and regional insights that significantly impact this dynamic industry. To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/1058 Steady Market Growth The global aircraft tyre market, valued at USD 1634.41 million in 2022, is anticipated to surge to
Global Automotive Interior Leather Market to Hit USD 61.6 Billion, Globally By 2030 at 6.50% CAGR | Infinium Global Research
Global Automotive Interior Leather Market to Hit USD 61.6 Billion, Globally By 2 …
Infinium Global Research, a leading research firm, has published an extensive report providing a detailed analysis of the Global Automotive Interior Leather Market. The report offers comprehensive insights into segments and sub-segments, highlighting both global trends and regional dynamics shaping this thriving industry. To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/1266 Steady Market Growth The global automotive interior leather market, valued at USD 30.82 billion in 2022, is projected to skyrocket
Global Automatic Car Wash Market Growing at a CAGR of 4.01% to Reach USD 5.82 Billion By 2030 | Infinium Global Research
Global Automatic Car Wash Market Growing at a CAGR of 4.01% to Reach USD 5.82 Bi …
Infinium Global Research, a leading authority in market analysis, has released an extensive report offering a deep dive into the Global Automatic Car Wash Market. The report presents an in-depth analysis of segments and sub-segments, shedding light on both global trends and regional dynamics impacting this burgeoning industry. To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/1295 Robust Market Growth The automatic car wash market, valued at USD 4.04 billion
Global Automotive Logistics Market is Anticipated to Reach USD 363.03 Billion at a Robust CAGR of 5.51% Between 2023 to 2030 | Infinium Global Research
Global Automotive Logistics Market is Anticipated to Reach USD 363.03 Billion at …
Infinium Global Research, a leading market research firm, has released an expansive report offering an in-depth analysis of the Global Automotive Logistics Market. The report delves into crucial segments and sub-segments, shedding light on both global and regional dynamics impacting this intricate industry. The comprehensive study reveals the profound impact of drivers, restraints, and macro indicators on the automotive logistics market. Providing a comprehensive outlook, the report highlights evolving trends, forecasts,

All 5 Releases


More Releases for Staphylococcus

Methicillin-Resistant Staphylococcus Aureus Testing Market Size, Share, Developm …
LP INFORMATION offers a latest published report on Methicillin-Resistant Staphylococcus Aureus Testing Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. According to this study, over the next five years the Methicillin-Resistant Staphylococcus Aureus Testing market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million
Staphylococcus Aureus Testing Market In-Depth Market Research Report 2027
A wide range of human clinical infection caused by Staphylococcus Aureus such as Skin, soft tissue, bacteremia, infective endocarditis and others are the major infection caused by Staphylococcus Aureus. The increased use of Staphylococcus Aureus testing in the diagnosis of staph infection grow rapidly, due to the availability of the various advanced test to screen the pathogen efficiently. There is a number of tests present in the market for Staphylococcus
Methicillin-resistant Staphylococcus Aureus Therapeutics Pipeline Analysis 2018
MRSA infection caused by specific "staph" bacteria that is often resistant to most of antibiotic treatments. S. aureus (SA) is listed as a ‘superbug’ by U.S. Centers for Disease Control and Prevention (CDC). MRSA can either be present harmlessly on the skin (colonization) or enter the body (e.g. through broken skin) and cause an infection. The study analyzed that MRSA infection therapeutics pipeline comprises approximately 52 drug candidates in different
Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market – Driver
Methicillin-Resistant Staphylococcus Aureus (MRSA) is a type of staphylococcus aureus, which became resistant to methicillin, amoxicillin, penicillin, oxacillin, and other such commonly used antibiotics. Staphylococcus aureus harbors on the skin and nasal passage of about one third of the world population, which comprises around 33%, as per Centers for Disease Control and Prevention (CDC) review 2015. MRSA can be classified into two types, based on mode of infection – Hospital
Vancomycin-Resistant Staphylococcus aureus Infections Pipeline Review H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections - Pipeline Review, H1 2017, provides an overview of the Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections (Infectious Disease) pipeline landscape. Vancomycin resistant staphylococcus infection is a condition caused by bacteria (germs) . This infection occurs when bacteria, called Staphylococcus aureus or Staph, becomes resistant (not killed) to the antibiotic medicine vancomycin. Risk factors include taking strong antibiotics the wrong
Market Forecast Report on Staphylococcus Aureus Testing Market 2017 – 2027
A wide range of human clinical infection caused by Staphylococcus Aureus such as Skin, soft tissue, bacteremia, infective endocarditis and others are the major infection caused by Staphylococcus Aureus. The increased use of Staphylococcus Aureus testing in the diagnosis of staph infection grow rapidly, due to the availability of the various advanced test to screen the pathogen efficiently. There is a number of tests present in the market for Staphylococcus